Explore intersection genes of oxymatrine and COVID-19 with lung cancer as potential therapeutic targets based on network pharmacology.
Oxymatrine, a natural alkaloid, has antiviral, anti-inflammatory, and immune regulatory effects. Research suggests it may be beneficial for lung cancer patients with COVID-19. Targets include immune regulation, cytoprotection, and control of signaling pathways. Oxymatrine may enhance current treatments for COVID-19 and lung cancer.
- Wu W et al (2023).
- J Med Microbiol.
- DOI:
- 10.1099/jmm.0.001766
- PubMed:
- 37855710